Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05432362 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ESAN II - Energy Sensing in Depression

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 27, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jan 31, 2024 to Jan 31, 2026v3
  2. Primary and study completion dates: Jan 31, 2023 to Jan 31, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Medical University of Graz
117 trials monitored
See 7 trials at risk
Obesity
3,560 trials monitored
See 142 trials at risk
Depression
2,998 trials monitored
See 166 trials at risk
The purpose of this study is to assess the effects of polyphenols from natural aronia juice on the immune system. Therefore, the study aims to distinguish the effects of natural juices that are rich in phytonutrients such as polyphenols and carotenoids in healthy and depressive subjects in order to use the known positive effects of these food sources in the therapeutic setting. The consumption of natural fruit juices that are rich in polyphenols and carotenoids mirror a model of vegetarian diet due to the increased micronutrient density derived from plant food. Results obtained here can be seen as preliminary explanation models for the beneficial effects of vegetarian diet. It is hypothesized, that the consumption of naturally polyphenol rich aronia juice changes the expression of regulatory T cells, specific cells of the immune system that contribute to immunomodulation. Furthermore, beneficial changes in the gut microbiome, the metabolome and the nutritional status are expected in the studied groups. The study was registered retrospectively (after start of recruitment) on Clinicaltrials.gov.
Trial Details
NCT Number NCT05432362
Lead Sponsor Medical University of Graz
Conditions Immune System Tolerance, Depression, Obesity, Microbial Colonization, Diet, Healthy
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov